How Can Cardiovascular Risk Be Reduced in Kidney Dialysis?
The experimental IL-6 inhibitor clazakizumab improves key inflammation markers in one study, whereas another shows lower risks with home hemodialysis vs peritoneal dialysis.
Stay updated with breaking news from Peter Stenvinkel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The experimental IL-6 inhibitor clazakizumab improves key inflammation markers in one study, whereas another shows lower risks with home hemodialysis vs peritoneal dialysis.
A team of European researchers has developed an innovative test that accurately measures biological aging in a clinical setting. The discovery was made while studying patients for the aging effects of chronic kidney disease. The new test is an epigenetic clock – a type of biochemical assessment t
<p><strong>A team of European researchers has developed a new test that can accurately measure biological aging in a clinical setting. The discovery was made while studying patients for the aging effects of chronic kidney disease.</strong></p>
UCLA cardiologist Barbara Natterson-Horowitz discusses the disproportionate effects of climate change on female animals, including women and girls.
/PRNewswire/ -- Invizius Limited ("Invizius"), a biotechnology company developing treatments to suppress unwanted immune responses in haemodialysis, is pleased...